We are looking for guidance on the recent stance of the inclusion or exclusion of modifiers with the 2019 eCQM specifications. In reference to a previous historical ticket,
CQM-2234 states "Currently, the recommended national standard tools used in electronic clinical quality measure specifications do not have the capability to include code modifiers (i.e., CPT modifiers), and code modifiers are not required for reporting on electronic clinical quality measures in the Meaningful Use program." However, the MIPS CQM specifications due provide guidance on a measure by measure basis on the inclusion/exclusion of modifiers in some measures such as 155, 69, 117, 131, 68, 127, 147, 137, 50, 177 and 66 with the following modifiers: GQ, GT, 95, 02, 1P, 2P, 3P, 8P.
Can you please provide guidance on the expectation of the implementation of eCQMs in regard to modifiers? Is the
CQM-2234 issue still current for this guidance?